Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro

Naftopidil (NAF) is widely used for the treatment of benign prostatic hyperplasia and prevention of prostate cancer in elderly men. These patients receive a combination of drugs, which involves high risk for drug–drug interaction. NAF exhibits superior efficacy but must be administered at a much hig...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xia-Wen Liu, Yi Rong, Xing-Fei Zhang, Jun-Jun Huang, Yi Cai, Bi-Yun Huang, Liu Zhu, Bo Wu, Ning Hou, Cheng-Feng Luo
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2018-01-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	naftopidil enantiomer metabolism UDP-glucuronosyltransferases microsomes
Accés en línia:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00984/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!